30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

4Q13/2013 Revenue: Baxano Surgical

4Q13 revenue: $6.0MM, +44% (U.S. $5.1MM, +70%; ex-U.S. $0.8MM, -27%)

  • iO-Flex $2.9MM, +17%
  • iO-Tome $0.09MM
  • VEO $0.5MM
  • AxiaLIF $2MM


2013 revenue: $18.6MM, +28%

  • VEO $0.8MM, +47%


  • Growth primarily attributed to acquired iO-Flex, offset by lower AxiaLIF cases following limited private payor reimbursement
  • Added 65 new iO-Flex surgeons in 2H
  • ~40% of sales force with company for 6 months or less
  • 2014 launches include Avance pedicle screw (2Q), will be reported within AxiaLIF or VEO numbers